Prenatal diagnosis of X-linked chronic granulomatous disease using restriction fragment length polymorphism analysis.
Prenatal diagnosis of X-linked chronic granulomatous disease (CGD) was performed with restriction fragment length polymorphism (RFLP) analysis using probes flanking the gene. The male fetus and an affected male displayed the same haplotype for RFLPs belonging to six linked loci extending from DXS164 to DXS7, which encompass the CGD locus, and for which the mother was heterozygous. Diagnosis of an affected fetus was confirmed after termination of the pregnancy by the study of fetal granulocytes using the nitroblue tetrazolium reduction test. In informative families prenatal diagnosis of CGD can be made earlier by RFLP analysis than by fetal blood sampling.
D004247:DNA / Q000235:genetics; D004303:Dosage Compensation, Genetic; D005260:Female; D005315:Fetal Diseases / Q000175:diagnosis; D008040:Genetic Linkage; D005819:Genetic Markers; D006098:Granulocytes / Q000502:physiology; D006105:Granulomatous Disease, Chronic / Q000175:diagnosis* / Q000235:genetics; D006801:Humans; D007223:Infant; D008297:Male; D009580:Nitroblue Tetrazolium; D011110:Polymorphism, Genetic; D012150:Polymorphism, Restriction Fragment Length; D011247:Pregnancy; D011296:Prenatal Diagnosis; D014960:X Chromosome
D005819:Genetic Markers; D009580:Nitroblue Tetrazolium; D004247:DNA